Literature DB >> 23062752

Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia.

Ori S Cohen1, Sarah Y Mccoy, Frank A Middleton, Sean Bialosuknia, Yanli Zhang-James, Lu Liu, Ming T Tsuang, Stephen V Faraone, Stephen J Glatt.   

Abstract

The diverse spatial and temporal expression of alternatively spliced transcript isoforms shapes neurodevelopment and plays a major role in neuronal adaptability. Although alternative splicing is extremely common in the brain, its role in mental illnesses such as schizophrenia has received little attention. To examine this relationship, postmortem brain tissue was obtained from 20 individuals with schizophrenia (SZ) and 20 neuropsychiatrically normal comparison subjects. Gray matter samples were extracted from two brain regions implicated in the disorder: Brodmann Area 10 and caudate. Affymetrix Human Gene 1.0 ST arrays were used on four subjects per group to attain an initial profile of differential expression of transcribed elements within and across brain regions in SZ. Numerous genes of interest with altered mRNA transcripts were identified by microarray through the differential expression of particular exons and 3' untranslated regions (UTRs) between diagnostic groups. Select microarray results--including dysregulation of ENAH exon 11a and CPNE3 3'UTR--were verified by qRTPCR and replicated in the remaining independent sample of 16 SZ patients and 16 normal comparison subjects. These results, if further replicated, clearly illustrate the importance of Identifying transcriptomic variants in expression studies, and implicate novel candidate genes in the disorder.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062752      PMCID: PMC3502694          DOI: 10.1016/j.schres.2012.09.015

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  29 in total

1.  Executive functioning-related brain abnormalities associated with the genetic liability for schizophrenia: an activation likelihood estimation meta-analysis.

Authors:  V M Goghari
Journal:  Psychol Med       Date:  2010-10-14       Impact factor: 7.723

Review 2.  Neuronal regulation of alternative pre-mRNA splicing.

Authors:  Qin Li; Ji-Ann Lee; Douglas L Black
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

3.  Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene.

Authors:  Anna K Kähler; Srdjan Djurovic; Bettina Kulle; Erik G Jönsson; Ingrid Agartz; Håkan Hall; Stein Opjordsmoen; Klaus D Jakobsen; Thomas Hansen; Ingrid Melle; Thomas Werge; Vidar M Steen; Ole A Andreassen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

Review 4.  Got diversity? Wiring the fly brain with Dscam.

Authors:  S Lawrence Zipursky; Woj M Wojtowicz; Daisuke Hattori
Journal:  Trends Biochem Sci       Date:  2006-08-21       Impact factor: 13.807

Review 5.  Analyzing schizophrenia by DNA microarrays.

Authors:  Szatmár Horváth; Zoltán Janka; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2011-01-15       Impact factor: 13.382

6.  Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain.

Authors:  Wee-Tin Kao; Yanhong Wang; Joel E Kleinman; Barbara K Lipska; Thomas M Hyde; Daniel R Weinberger; Amanda J Law
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

7.  Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.

Authors:  Kevin Yu; Charlton Cheung; Meikei Leung; Qi Li; Siew Chua; Gráinne McAlonan
Journal:  Front Hum Neurosci       Date:  2010-10-26       Impact factor: 3.169

8.  Asymmetric localization of Numb:EGFP in dividing neuroepithelial cells during neurulation in Danio rerio.

Authors:  Alexander M Reugels; Barbara Boggetti; Nico Scheer; José A Campos-Ortega
Journal:  Dev Dyn       Date:  2006-04       Impact factor: 3.780

9.  DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms.

Authors:  Kenji Nakata; Barbara K Lipska; Thomas M Hyde; Tianzhang Ye; Erin N Newburn; Yukitaka Morita; Radhakrishna Vakkalanka; Maxim Barenboim; Yoshitatsu Sei; Daniel R Weinberger; Joel E Kleinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

10.  Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease.

Authors:  Natalie A Twine; Karolina Janitz; Marc R Wilkins; Michal Janitz
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

View more
  15 in total

Review 1.  The developmental transcriptome of the human brain: implications for neurodevelopmental disorders.

Authors:  Andrew T N Tebbenkamp; A Jeremy Willsey; Matthew W State; Nenad Sestan
Journal:  Curr Opin Neurol       Date:  2014-04       Impact factor: 5.710

Review 2.  Postmortem brain tissue as an underutilized resource to study the molecular pathology of neuropsychiatric disorders across different ethnic populations.

Authors:  Eric Vornholt; Dan Luo; Wenying Qiu; Gowon O McMichael; Yangyang Liu; Nathan Gillespie; Chao Ma; Vladimir I Vladimirov
Journal:  Neurosci Biobehav Rev       Date:  2019-04-24       Impact factor: 8.989

3.  Low CPNE3 expression is associated with risk of acute myocardial infarction: A feasible genetic marker of acute myocardial infarction in patients with stable coronary artery disease.

Authors:  Buchuan Tan; Long Liu; Yushuang Yang; Qian Liu; Liping Yang; Fanbo Meng
Journal:  Cardiol J       Date:  2018-01-03       Impact factor: 2.737

Review 4.  The Long Non-Coding RNA GOMAFU in Schizophrenia: Function, Disease Risk, and Beyond.

Authors:  Paul M Zakutansky; Yue Feng
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

Review 5.  Recent Advances in the Genetics of Schizophrenia.

Authors:  Dimitrios Avramopoulos
Journal:  Mol Neuropsychiatry       Date:  2018-05-30

Review 6.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

7.  Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.

Authors:  Mihovil Mladinov; Goran Sedmak; Heidi R Fuller; Mirjana Babić Leko; Davor Mayer; Jason Kirincich; Andrija Štajduhar; Fran Borovečki; Patrick R Hof; Goran Šimić
Journal:  Transl Neurosci       Date:  2016-11-27       Impact factor: 1.757

8.  8p21.3 deletions are rare causes of non-syndromic autism spectrum disorder.

Authors:  Nele Cosemans; Jarymke Maljaars; Annick Vogels; Maureen Holvoet; Koen Devriendt; Jean Steyaert; Kris Van Den Bogaert; Ilse Noens; Hilde Peeters
Journal:  Neurogenetics       Date:  2021-03-08       Impact factor: 2.660

9.  Genetic Control of Expression and Splicing in Developing Human Brain Informs Disease Mechanisms.

Authors:  Rebecca L Walker; Gokul Ramaswami; Christopher Hartl; Nicholas Mancuso; Michael J Gandal; Luis de la Torre-Ubieta; Bogdan Pasaniuc; Jason L Stein; Daniel H Geschwind
Journal:  Cell       Date:  2019-10-17       Impact factor: 66.850

10.  Modeling a linkage between blood transcriptional expression and activity in brain regions to infer the phenotype of schizophrenia patients.

Authors:  El Chérif Ibrahim; Vincent Guillemot; Magali Comte; Arthur Tenenhaus; Xavier Yves Zendjidjian; Aida Cancel; Raoul Belzeaux; Florence Sauvanaud; Olivier Blin; Vincent Frouin; Eric Fakra
Journal:  NPJ Schizophr       Date:  2017-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.